APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crohn’s Disease Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Crohn’s Disease Drug Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchCrohn’s Disease Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Crohn’s Disease Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Crohn’s Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crohn’s Disease Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Crohn’s Disease Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Crohn’s Disease Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Crohn’s Disease Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Crohn’s Disease Drug market include Janssen Biotech, Takeda Pharmaceuticals, Amgen, AbbVie and Tillotts Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Crohn’s Disease Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Crohn’s Disease Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Crohn’s Disease Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Crohn’s Disease Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Crohn’s Disease Drug Segment by Company

Janssen Biotech

Takeda Pharmaceuticals

Amgen

AbbVie

Tillotts Pharma

Crohn’s Disease Drug Segment by Type

Aminosalicylates (5-ASA)

Antibiotics

Immunomodulators

Corticosteroids

Crohn’s Disease Drug Segment by Application

Pediatric Crohn'S Disease

Maintaining Remission (Prevention Of Flare-Ups)

Achieving Remission (The Absence Of Symptoms)

Crohn’s Disease Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Crohn’s Disease Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Crohn’s Disease Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Crohn’s Disease Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Crohn’s Disease Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Crohn’s Disease Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Crohn’s Disease Drug industry.

Chapter 3: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Crohn’s Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Crohn’s Disease Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Crohn’s Disease Drug Industry Trends Table 2. Crohn’s Disease Drug Industry Drivers Table 3. Crohn’s Disease Drug Industry Opportunities and Challenges Table 4. Crohn’s Disease Drug Industry Restraints Table 5. Global Crohn’s Disease Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Crohn’s Disease Drug Revenue Share by Company (2021-2026) Table 7. Global Crohn’s Disease Drug Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Crohn’s Disease Drug Sales Volume Share by Company (2021-2026) Table 9. Global Crohn’s Disease Drug Average Price (US$/ton) of Company (2021-2026) Table 10. Global Crohn’s Disease Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Crohn’s Disease Drug Key Company Manufacturing Base & Headquarters Table 12. Global Crohn’s Disease Drug Company, Product Type & Application Table 13. Global Crohn’s Disease Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Crohn’s Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Aminosalicylates (5-ASA) Table 18. Significant Companies of Antibiotics Table 19. Significant Companies of Immunomodulators Table 20. Significant Companies of Corticosteroids Table 21. Global Crohn’s Disease Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 22. Global Crohn’s Disease Drug Sales Volume by Type (2021-2026) & (k tons) Table 23. Global Crohn’s Disease Drug Sales Volume by Type (2027-2032) & (k tons) Table 24. Global Crohn’s Disease Drug Sales Volume Share by Type (2021-2026) Table 25. Global Crohn’s Disease Drug Sales Volume Share by Type (2027-2032) Table 26. Global Crohn’s Disease Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Crohn’s Disease Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Crohn’s Disease Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Crohn’s Disease Drug Sales Value Share by Type (2021-2026) Table 30. Global Crohn’s Disease Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pediatric Crohn'S Disease Table 32. Significant Companies of Maintaining Remission (Prevention Of Flare-Ups) Table 33. Significant Companies of Achieving Remission (The Absence Of Symptoms) Table 34. Global Crohn’s Disease Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 35. Global Crohn’s Disease Drug Sales Volume by Application (2021-2026) & (k tons) Table 36. Global Crohn’s Disease Drug Sales Volume by Application (2027-2032) & (k tons) Table 37. Global Crohn’s Disease Drug Sales Volume Share by Application (2021-2026) Table 38. Global Crohn’s Disease Drug Sales Volume Share by Application (2027-2032) Table 39. Global Crohn’s Disease Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Crohn’s Disease Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Crohn’s Disease Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Crohn’s Disease Drug Sales Value Share by Application (2021-2026) Table 43. Global Crohn’s Disease Drug Sales Value Share by Application (2027-2032) Table 44. Global Crohn’s Disease Drug Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 45. Global Crohn’s Disease Drug Sales by Region (2021-2026) & (k tons) Table 46. Global Crohn’s Disease Drug Sales Market Share by Region (2021-2026) Table 47. Global Crohn’s Disease Drug Sales by Region (2027-2032) & (k tons) Table 48. Global Crohn’s Disease Drug Sales Market Share by Region (2027-2032) Table 49. Global Crohn’s Disease Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Crohn’s Disease Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Crohn’s Disease Drug Sales Value Share by Region (2021-2026) Table 52. Global Crohn’s Disease Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Crohn’s Disease Drug Sales Value Share by Region (2027-2032) Table 54. Global Crohn’s Disease Drug Market Average Price (US$/ton) by Region (2021-2026) Table 55. Global Crohn’s Disease Drug Market Average Price (US$/ton) by Region (2027-2032) Table 56. Global Crohn’s Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. Global Crohn’s Disease Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 59. Global Crohn’s Disease Drug Sales Market Share by Country (2021-2026) Table 60. Global Crohn’s Disease Drug Sales by Country (2027-2032) & (k tons) Table 61. Global Crohn’s Disease Drug Sales Market Share by Country (2027-2032) Table 62. Global Crohn’s Disease Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Crohn’s Disease Drug Sales Value Market Share by Country (2021-2026) Table 64. Global Crohn’s Disease Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Crohn’s Disease Drug Sales Value Market Share by Country (2027-2032) Table 66. Janssen Biotech Company Information Table 67. Janssen Biotech Business Overview Table 68. Janssen Biotech Crohn’s Disease Drug Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 69. Janssen Biotech Crohn’s Disease Drug Product Portfolio Table 70. Janssen Biotech Recent Development Table 71. Takeda Pharmaceuticals Company Information Table 72. Takeda Pharmaceuticals Business Overview Table 73. Takeda Pharmaceuticals Crohn’s Disease Drug Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio Table 75. Takeda Pharmaceuticals Recent Development Table 76. Amgen Company Information Table 77. Amgen Business Overview Table 78. Amgen Crohn’s Disease Drug Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Amgen Crohn’s Disease Drug Product Portfolio Table 80. Amgen Recent Development Table 81. AbbVie Company Information Table 82. AbbVie Business Overview Table 83. AbbVie Crohn’s Disease Drug Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. AbbVie Crohn’s Disease Drug Product Portfolio Table 85. AbbVie Recent Development Table 86. Tillotts Pharma Company Information Table 87. Tillotts Pharma Business Overview Table 88. Tillotts Pharma Crohn’s Disease Drug Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Tillotts Pharma Crohn’s Disease Drug Product Portfolio Table 90. Tillotts Pharma Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Crohn’s Disease Drug Distributors List Table 94. Crohn’s Disease Drug Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Crohn’s Disease Drug Product Image Figure 2. Global Crohn’s Disease Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crohn’s Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Crohn’s Disease Drug Sales (2021-2032) & (k tons) Figure 5. Global Crohn’s Disease Drug Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Crohn’s Disease Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Aminosalicylates (5-ASA) Image Figure 10. Antibiotics Image Figure 11. Immunomodulators Image Figure 12. Corticosteroids Image Figure 13. Global Crohn’s Disease Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Crohn’s Disease Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Crohn’s Disease Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Crohn’s Disease Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Crohn’s Disease Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Crohn’s Disease Drug Sales Value Share by Type (2021-2032) Figure 19. Pediatric Crohn'S Disease Image Figure 20. Maintaining Remission (Prevention Of Flare-Ups) Image Figure 21. Achieving Remission (The Absence Of Symptoms) Image Figure 22. Global Crohn’s Disease Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 23. Global Crohn’s Disease Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Crohn’s Disease Drug Sales Volume Share by Application (2021-2032) Figure 25. Global Crohn’s Disease Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Crohn’s Disease Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Crohn’s Disease Drug Sales Value Share by Application (2021-2032) Figure 28. Global Crohn’s Disease Drug Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 29. Global Crohn’s Disease Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Crohn’s Disease Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Crohn’s Disease Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Crohn’s Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America Crohn’s Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Crohn’s Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Crohn’s Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Crohn’s Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Crohn’s Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Crohn’s Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America Crohn’s Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Crohn’s Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Crohn’s Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Crohn’s Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Crohn’s Disease Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Crohn’s Disease Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Aminosalicylates (5-ASA)
  • Antibiotics
  • Immunomodulators
  • Corticosteroids
Applications
  • Pediatric Crohn'S Disease
  • Maintaining Remission (Prevention Of Flare-Ups)
  • Achieving Remission (The Absence Of Symptoms)
Companies covered
  • Janssen Biotech
  • Takeda Pharmaceuticals
  • Amgen
  • AbbVie
  • Tillotts Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crohn’s Disease Drug Sales Value (2021-2032)
  4. 1.2.2 Global Crohn’s Disease Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Crohn’s Disease Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Crohn’s Disease Drug Market Dynamics
  1. 2.1 Crohn’s Disease Drug Industry Trends
  2. 2.2 Crohn’s Disease Drug Industry Drivers
  3. 2.3 Crohn’s Disease Drug Industry Opportunities and Challenges
  4. 2.4 Crohn’s Disease Drug Industry Restraints
3 Crohn’s Disease Drug Market by Company
  1. 3.1 Global Crohn’s Disease Drug Company Revenue Ranking in 2025
  2. 3.2 Global Crohn’s Disease Drug Revenue by Company (2021-2026)
  3. 3.3 Global Crohn’s Disease Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Crohn’s Disease Drug Average Price by Company (2021-2026)
  5. 3.5 Global Crohn’s Disease Drug Company Ranking (2024-2026)
  6. 3.6 Global Crohn’s Disease Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Crohn’s Disease Drug Company Product Type and Application
  8. 3.8 Global Crohn’s Disease Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Crohn’s Disease Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Crohn’s Disease Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Crohn’s Disease Drug Market by Type
  1. 4.1 Crohn’s Disease Drug Type Introduction
  2. 4.1.1 Aminosalicylates (5-ASA)
  3. 4.1.2 Antibiotics
  4. 4.1.3 Immunomodulators
  5. 4.1.4 Corticosteroids
  6. 4.2 Global Crohn’s Disease Drug Sales Volume by Type
  7. 4.2.1 Global Crohn’s Disease Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Crohn’s Disease Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Crohn’s Disease Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Crohn’s Disease Drug Sales Value by Type
  11. 4.3.1 Global Crohn’s Disease Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Crohn’s Disease Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Crohn’s Disease Drug Sales Value Share by Type (2021-2032)
5 Crohn’s Disease Drug Market by Application
  1. 5.1 Crohn’s Disease Drug Application Introduction
  2. 5.1.1 Pediatric Crohn'S Disease
  3. 5.1.2 Maintaining Remission (Prevention Of Flare-Ups)
  4. 5.1.3 Achieving Remission (The Absence Of Symptoms)
  5. 5.2 Global Crohn’s Disease Drug Sales Volume by Application
  6. 5.2.1 Global Crohn’s Disease Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Crohn’s Disease Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Crohn’s Disease Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Crohn’s Disease Drug Sales Value by Application
  10. 5.3.1 Global Crohn’s Disease Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Crohn’s Disease Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Crohn’s Disease Drug Sales Value Share by Application (2021-2032)
6 Crohn’s Disease Drug Regional Sales and Value Analysis
  1. 6.1 Global Crohn’s Disease Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Crohn’s Disease Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Crohn’s Disease Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Crohn’s Disease Drug Sales by Region (2027-2032)
  5. 6.3 Global Crohn’s Disease Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Crohn’s Disease Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Crohn’s Disease Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Crohn’s Disease Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Crohn’s Disease Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Crohn’s Disease Drug Sales Value (2021-2032)
  12. 6.6.2 North America Crohn’s Disease Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Crohn’s Disease Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Crohn’s Disease Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Crohn’s Disease Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Crohn’s Disease Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Crohn’s Disease Drug Sales Value (2021-2032)
  21. 6.9.2 South America Crohn’s Disease Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Crohn’s Disease Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Crohn’s Disease Drug Sales Value Share by Country, 2025 VS 2032
7 Crohn’s Disease Drug Country-level Sales and Value Analysis
  1. 7.1 Global Crohn’s Disease Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Crohn’s Disease Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Crohn’s Disease Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Crohn’s Disease Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Crohn’s Disease Drug Sales by Country (2027-2032)
  6. 7.4 Global Crohn’s Disease Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Crohn’s Disease Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Crohn’s Disease Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Crohn’s Disease Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Crohn’s Disease Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Crohn’s Disease Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Biotech
  2. 8.1.1 Janssen Biotech Company Information
  3. 8.1.2 Janssen Biotech Business Overview
  4. 8.1.3 Janssen Biotech Crohn’s Disease Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Biotech Crohn’s Disease Drug Product Portfolio
  6. 8.1.5 Janssen Biotech Recent Developments
  7. 8.2 Takeda Pharmaceuticals
  8. 8.2.1 Takeda Pharmaceuticals Company Information
  9. 8.2.2 Takeda Pharmaceuticals Business Overview
  10. 8.2.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio
  12. 8.2.5 Takeda Pharmaceuticals Recent Developments
  13. 8.3 Amgen
  14. 8.3.1 Amgen Company Information
  15. 8.3.2 Amgen Business Overview
  16. 8.3.3 Amgen Crohn’s Disease Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Crohn’s Disease Drug Product Portfolio
  18. 8.3.5 Amgen Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Crohn’s Disease Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Crohn’s Disease Drug Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 Tillotts Pharma
  26. 8.5.1 Tillotts Pharma Company Information
  27. 8.5.2 Tillotts Pharma Business Overview
  28. 8.5.3 Tillotts Pharma Crohn’s Disease Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Tillotts Pharma Crohn’s Disease Drug Product Portfolio
  30. 8.5.5 Tillotts Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Crohn’s Disease Drug Value Chain Analysis
  2. 9.1.1 Crohn’s Disease Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Crohn’s Disease Drug Sales Mode & Process
  6. 9.2 Crohn’s Disease Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Crohn’s Disease Drug Distributors
  9. 9.2.3 Crohn’s Disease Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst